The NHS is drawing up plans for a Covid injection booster programme that would roll out third shots of the vaccine to millions of the most vulnerable people in the UK from September. Public health officials are keen to offer the shots alongside winter flu jabs. The move follows interim advice from the Joint Committee on Vaccination and Immunisation for the health service to prepare a two-stage autumn booster programme pending a final decision in the summer on whether to proceed.
Those who are most vulnerable will be offer a third dose A Covid-19 vaccination booster programme could begin for 32 million Britons as soon as September, officials have said. New interim guidance from experts advising the Government sets out the priority list for who should get a third jab if a booster programme is needed.
BORIS JOHNSON addressed the nation yesterday evening in response to fears about the Indian Covid variant (B1.617.2).The super contagious mutant strain has been spreading in hotspots such as Bolton and London, and is growing elsewhere.Boris Johnson discusses future of coronavirus travel restrictions Chair of the Joint Committee on Vaccination and Immunisation (JCVI), Professor Wei Shen Lim, advised government to bring forward the second dose of the Covid vaccine from 12 to eight weeks.
The Government confirmed under 40s will be offered an alternative to the AstraZeneca/Oxford vaccine, along with those under 30 Vaccine experts have issued an urgent warning to anybody who has received the AstraZeneca/Oxford jab.People who have received either one or both doses of the AZ jab are being urged to look out for five worrying symptoms.
Seek prompt medical advice if you have any of these symptoms A warning has been issued by Covid-19 vaccine experts to anyone who has received the AstraZeneca/Oxford jab.Those who have had it are being urged to look out for five symptoms which could indicate problems, reports Birmingham Live.
Covid-19 vaccine experts have issued warnings to anybody who has received the AstraZeneca/Oxford jab This week is was revealed that under 40s will be offered an alternative to the Oxford/AstraZeneca coronavirus vaccine.The Joint Committee on Vaccination and Immunisation (JCVI) made the decision after confirming there is an 'extremely small risk' of people suffering rare blood clots after having the jab.
UNDER-40s are to be offered an alternative to the Oxford/AstraZeneca vaccine.This is due to the blood clot risk the vaccine carries.However, for the many people who have already had this type of jab, they're being issued a warning.Covid experts are urging people who have had the AstraZeneca vaccine to be wary of five troubling after effects that could be dangerous.
Pregnant women trying to get the preferred coronavirus vaccine have faced confusion, delays and wasted trips, a charity has said.The Joint Committee on Vaccination and Immunisation (JCVI) advises that it is “preferable” for pregnant women in the UK to be offered the Pfizer-BioNTech and Moderna vaccines where available.
'Safety remains our number one priority' Adults in the UK under the age of 40 will be offered an alternative to the Oxford-AstraZeneca due to its link with rare blood clots.The availability of other vaccines - such as Pfizer and Moderna - has also played a part in the decision.
PEOPLE under the age of 40 will be offered an alternative vaccine to the Oxford/AstraZeneca jab following a review from the Joint Committee on Vaccination and Immunisation (JCVI).People under the age of 40 will be offered an alternative vaccine to the AstraZeneca/Oxford jab, according to the JCVI.
Pregnant women should be offered a Covid-19 jab at the same time as the rest of the population based on their age and clinical risk group, according to new official advice. The Joint Committee on Vaccination and Immunisation (JCVI) said there were “no specific safety concerns” identified with “any brand of Covid-19 vaccines” in relation to pregnancy. It said data from the US showed around 90,000 pregnant women had received jabs, mainly the Pfizer-BioNTech and Moderna vaccines, “without any safety concerns
Pregnant women are to be offered a Covidvaccination at the same time as other people their age as part of the UK vaccination roll out. In new advice the government’s Joint Committee on Vaccination and Immunisation (JCVI) said there were no safety concerns identified for pregnant women or their babies. Women will be able to have the dose at any stage during their pregnancy. The decision comes after new data from the United States where almost 90,000 pregnant women have been vaccinated with the Pfizer/BioNTech
People over the age of 16 living with adults with a weakened immune system are to be prioritised for coronavirus jabs in Wales.Adults who are immunosuppressed have a weaker immune system to fight infections naturally and are more likely to have poorer outcomes after contracting coronavirus.This includes those with blood cancer, HIV or those who are having immunosuppressive treatment.
People over 16 in households of adults with a weakened immune system are to be prioritised for Covid-19 jabs in Wales.Adults who are immunosuppressed have a weaker immune system to fight infections naturally and are more likely to have poorer outcomes after contracting coronavirus.This includes those with blood cancer, HIV or those who are having immunosuppressive treatment.
The Medicines and Healthcare products Regulatory Agency has now linked the Astra/Zeneca jab to 79 cases of blood clots and 19 deaths and under-30s will be offered another vaccine in the UK The under-30s will not be given the jab in future Brits have been urged to continue to take the Covid
Scientists urge 18 to 29-year-olds not to demand alternative jab, saying small risk from blood clotting preferable to mixing vaccines Young people who have received their first Oxford/AstraZeneca vaccine dose should get the second despite fears over blood clotting, officials said on Wednesday night.
BRITAIN should not give Oxford University/AstraZeneca's vaccine to under 30s where possible, Britain's Joint Committee on Vaccination and Immunisation (JCVI) said on Wednesday, due to a very rare side effect of blood clots in the brain.